Cargando…

Development of a new bicistronic retroviral vector with strong IRES activity

BACKGROUND: Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being i...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Patrick, Albagli, Olivier, Poggi, Marie Christine, Boulukos, Kim E, Pognonec, Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373653/
https://www.ncbi.nlm.nih.gov/pubmed/16409632
http://dx.doi.org/10.1186/1472-6750-6-4
_version_ 1782126808889556992
author Martin, Patrick
Albagli, Olivier
Poggi, Marie Christine
Boulukos, Kim E
Pognonec, Philippe
author_facet Martin, Patrick
Albagli, Olivier
Poggi, Marie Christine
Boulukos, Kim E
Pognonec, Philippe
author_sort Martin, Patrick
collection PubMed
description BACKGROUND: Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being investigated through the observation of an easily detectable tracer, such as Green Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to another, despite their apparent identical IRES sequences. We investigated the molecular basis for these discrepancies. RESULTS: We observed up to a 10 fold difference in IRES-controlled expression from distinct bicistronic expression vectors harboring the same apparent IRES sequences. We show that the insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is responsible for the dramatic loss of expression from the second cistron, whereas expression from the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function that detection of the IRES-controlled product can be difficult, and sometimes even below the levels of detection. It is striking to observe that this deleterious modification is widely found in available IRES-containing vectors, including commercial ones, despite early reports in the literature stating the importance of the integrity of the initiation codon for optimal IRES function. CONCLUSION: From these observations, we engineered a new vector family, pPRIG, which respects the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second cistron (here encoding eGFP).
format Text
id pubmed-1373653
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13736532006-02-18 Development of a new bicistronic retroviral vector with strong IRES activity Martin, Patrick Albagli, Olivier Poggi, Marie Christine Boulukos, Kim E Pognonec, Philippe BMC Biotechnol Methodology Article BACKGROUND: Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology. Among applications, the expression of two proteins under the control of a unique promoter permits the monitoring of expression of a protein whose biological function is being investigated through the observation of an easily detectable tracer, such as Green Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to another, despite their apparent identical IRES sequences. We investigated the molecular basis for these discrepancies. RESULTS: We observed up to a 10 fold difference in IRES-controlled expression from distinct bicistronic expression vectors harboring the same apparent IRES sequences. We show that the insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is responsible for the dramatic loss of expression from the second cistron, whereas expression from the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function that detection of the IRES-controlled product can be difficult, and sometimes even below the levels of detection. It is striking to observe that this deleterious modification is widely found in available IRES-containing vectors, including commercial ones, despite early reports in the literature stating the importance of the integrity of the initiation codon for optimal IRES function. CONCLUSION: From these observations, we engineered a new vector family, pPRIG, which respects the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second cistron (here encoding eGFP). BioMed Central 2006-01-12 /pmc/articles/PMC1373653/ /pubmed/16409632 http://dx.doi.org/10.1186/1472-6750-6-4 Text en Copyright © 2006 Martin et al; licensee BioMed Central Ltd.
spellingShingle Methodology Article
Martin, Patrick
Albagli, Olivier
Poggi, Marie Christine
Boulukos, Kim E
Pognonec, Philippe
Development of a new bicistronic retroviral vector with strong IRES activity
title Development of a new bicistronic retroviral vector with strong IRES activity
title_full Development of a new bicistronic retroviral vector with strong IRES activity
title_fullStr Development of a new bicistronic retroviral vector with strong IRES activity
title_full_unstemmed Development of a new bicistronic retroviral vector with strong IRES activity
title_short Development of a new bicistronic retroviral vector with strong IRES activity
title_sort development of a new bicistronic retroviral vector with strong ires activity
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373653/
https://www.ncbi.nlm.nih.gov/pubmed/16409632
http://dx.doi.org/10.1186/1472-6750-6-4
work_keys_str_mv AT martinpatrick developmentofanewbicistronicretroviralvectorwithstrongiresactivity
AT albagliolivier developmentofanewbicistronicretroviralvectorwithstrongiresactivity
AT poggimariechristine developmentofanewbicistronicretroviralvectorwithstrongiresactivity
AT boulukoskime developmentofanewbicistronicretroviralvectorwithstrongiresactivity
AT pognonecphilippe developmentofanewbicistronicretroviralvectorwithstrongiresactivity